🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates nivolumab in combination drug treatments involving 1) ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02357732
Treatments Being Tested
This is a phase 1 dose-escalation study of nilotinib in combination with fi...
Status
Recruiting
Location
University of Iowa
Start Date
2022-06-01
Trial ID
NCT04903119
The main purpose of this study is to explore the feasibility of selecting t...
Status
Recruiting
Location
Tianjin Medical Unversity Second Hospital
Start Date
2024-11-01
Trial ID
NCT06739395
Dabrafenib and trametinib are drugs that are usually given for the treatmen...
Status
Terminated
Location
QEII Health Sciences Centre
Start Date
2018-02-09
Trial ID
NCT02974803
Treatments Being Tested
This prospective, multi-centre, open label, non-randomised phase II trial a...
Status
Unknown
Location
Royal North Shore Hospital
Start Date
2022-07-14
Trial ID
NCT05182931
Treatments Being Tested
This feasibility study aims to determine if intermittent dosing is delivera...
Status
Completed
Location
Addenbrooke's Hospital
Start Date
2017-11-03
Trial ID
NCT03352947
Treatments Being Tested
Radioactive iodine therapy is often part of the standard treatment for Papi...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2012-07
Trial ID
NCT01534897
Treatments Being Tested
Colorectal cancer (CRC) is the second leading cause of cancer-related death...
Status
Recruiting
Location
Peking union medical college hospital
Start Date
2026-03-01
Trial ID
NCT07506109
Treatments Being Tested
This is an open label, single centre, phase II study of neoadjuvant drug tr...
Status
Completed
Location
Melanoma Institute Australia
Start Date
2014-10-01
Trial ID
NCT01972347
Treatments Being Tested
This was a Phase II, multicenter, non-randomized, open-label study to asses...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08-05
Trial ID
NCT01336634
Treatments Being Tested